[1]
A. Lo Gullo, G. Mandraffino, C. Aragona, A. Molica Colella, A. Saitta, and E. Imbalzano, “Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis”, Reumatismo, vol. 69, no. 4, pp. 184–188, Dec. 2017.